Informed Consent for an Off-Label Procedure
A 45-year-old woman with chronic migraines has failed multiple preventive medications. Her neurologist recommends a trial of greater occipital nerve block (GONB) with a mixture of local anesthetic and corticosteroid. However, the use of corticosteroid in this block is off-label in her country. The patient is eager to try anything to reduce her headaches. The neurologist has performed this procedure many times and believes it is effective based on personal experience and some case series. The clinic's policy requires informed consent for all procedures, but does not specifically address off-label use. The neurologist has a busy schedule and typically obtains verbal consent, documenting a brief note. The patient asks: "Is this safe? Will it work?"
1. What are the ethical and legal requirements for obtaining informed consent for this off-label procedure? Discuss what must be disclosed.
Read the worked answer
Ethical/legal requirements: Informed consent must be obtained for any procedure, including off-label use. The consent should be written and include: (1) the nature of the procedure and its purpose; (2) the off-label status of the corticosteroid and the evidence base (case series, not FDA-approved for this indication); (3) reasonable alternatives (e.g., other preventive medications, botulinum toxin, nerve stimulators); (4) material risks (infection, bleeding, nerve injury, steroid side effects like skin atrophy, adrenal suppression, hyperglycemia); (5) expected benefits and likelihood of success (based on limited evidence); (6) the patient's right to refuse or withdraw. Verbal consent with a brief note is inadequate for an off-label procedure; documentation should be thorough. The clinician must ensure the patient understands and voluntarily agrees. Legal risk: malpractice if insufficient disclosure leads to harm.
2. How should the neurologist respond to the patient's questions about safety and efficacy, given the limited evidence?
Read the worked answer
The neurologist should provide a balanced, honest response: "This procedure is not approved by regulatory agencies for migraine prevention, but it is used off-label based on some studies and clinical experience. The evidence is limited; some patients get significant relief, but it does not work for everyone. The risks include temporary soreness, bleeding, infection, and steroid effects. We will monitor you closely." Avoid overpromising. Discuss the uncertainty and the patient's goals. Offer to share published data if available. Document the discussion. This respects patient autonomy and supports shared decision-making.